Claris Biotherapeutics, Inc.
BiotechnologyBiotechnology
Jersey City, NJ
About
Claris Biotherapeutics, Inc. is a pioneering biotechnology company dedicated to the development of innovative therapies specifically aimed at treating corneal diseases. With a particular focus on neurotrophic keratitis (NK), a rare and debilitating condition that can lead to significant vision loss, Claris is committed to addressing critical unmet medical needs in this niche area of ocular health.
Company Values
Claris stands out by leveraging its proprietary technology platform based on recombinant human variant hepatocyte growth factor (dHGF), aiming to not only treat neurotrophic keratitis but also potentially other corneal conditions.